International Journal of Innovative Science and Research Technology (IJISRT),
Год журнала:
2024,
Номер
unknown, С. 2585 - 2591
Опубликована: Июнь 11, 2024
The
onset
of
Coronavirus
disease
2019
(COVID-19)
in
late
presented
a
severe
worldwide
health
crisis
with
widespread
morbidity
and
mortality.
Various
vaccine
platforms
have
been
rapidly
developed
approved
for
broad
use
swift
urgent
response
to
prevent
the
transmission
Severe
Acute
Respiratory
Syndrome
2
(SARS-CoV-2)
infection.
However,
these
vaccines
differ
significantly
terms
safety.
Heterologous
prime-boost
vaccination
enhances
safety
compared
homologous
vaccination,
although
it
could
lead
higher
cumulative
number
transient
adverse
events
reported
at
each
visit.
Therefore,
additional
strategies
are
necessary
improve
SARS-
CoV-2
Anecdotal
options
suggest
that
co-administration
can
reduce
effects
consequently,
avert
need
frequent
booster
doses.
This
study
reports
immunization
outcomes
against
SARS-CoV-2
virus
by
assessing
profiles
different
co-administered
BALB/c
mice.
Vaccine
combinations
comprising
mRNA/adenovirus26-vector,
mRNA/inactivated,
adenovirus26-vector/inactivated,
mRNA/adenovirus26-vector/inactivated
were
prepared
optimized
doses,
their
activities
upon
evaluated
comparison
individual
mRNA,
adenovirus26-vectored
inactivated
vaccines.
Twenty-eight
days
post-immunization,
various
treatments
through
hematological
biochemical
examination.
Importantly,
regimens
proved
safe
well-tolerated
mice,
as
evidenced
normal
values.
Advanced Materials,
Год журнала:
2024,
Номер
36(26)
Опубликована: Апрель 7, 2024
Abstract
Brain
disorders
represent
a
significant
challenge
in
medical
science
due
to
the
formidable
blood–brain
barrier
(BBB),
which
severely
limits
penetration
of
conventional
therapeutics,
hindering
effective
treatment
strategies.
This
review
delves
into
innovative
realm
biomimetic
nanodelivery
systems,
including
stem
cell‐derived
nanoghosts,
tumor
cell
membrane‐coated
nanoparticles,
and
erythrocyte
membrane‐based
carriers,
highlighting
their
potential
circumvent
BBB's
restrictions.
By
mimicking
native
properties,
these
nanocarriers
emerge
as
promising
solution
for
enhancing
drug
delivery
brain,
offering
strategic
advantage
overcoming
barrier's
selective
permeability.
The
unique
benefits
leveraging
membranes
from
various
sources
is
evaluated
advanced
technologies
fabricating
membrane‐encapsulated
nanoparticles
capable
masquerading
endogenous
cells
are
examined.
enables
targeted
broad
spectrum
therapeutic
agents,
ranging
small
molecule
drugs
proteins,
thereby
providing
an
approach
neurocare.
Further,
contrasts
capabilities
limitations
with
traditional
methods,
underlining
enable
targeted,
sustained,
minimally
invasive
modalities.
concluded
perspective
on
clinical
translation
underscoring
transformative
impact
landscape
intractable
brain
diseases.
Journal of Thrombosis and Haemostasis,
Год журнала:
2022,
Номер
20(11), С. 2475 - 2484
Опубликована: Авг. 18, 2022
Abstract
Inflammation
and
coagulation
are
the
critical
responses
to
infection
that
include
leukocytes,
platelets,
vascular
endothelial
cells
responding
in
concert
eradicate
invading
pathogen.
In
sepsis,
a
variety
of
cell
surface
receptors,
including
toll‐like
Fcγ‐receptors,
G‐protein‐coupled
adhesion
detect
pathogens
elicit
thromboinflammatory
responses.
Concurrently,
molecular
patterns
released
from
host
damaged
accelerate
immune
through
binding
same
pattern
recognition
receptors.
Cytokines,
chemokines,
extracellular
vesicles
important
mediators
for
amplifying
distant
as
part
systemic
response
infections.
At
time,
communicate
with
each
other
via
direct
contact,
molecules,
paracrine
mediators,
tunneling
nanotubes,
which
regulating
inflammation
thrombus
formation.
Despite
increasing
attention
immunothrombosis
these
close
communication
systems
less
understood
but
play
role
defense
mechanisms.
this
review,
cellular
activation
intercellular
sepsis
focus
on
will
be
considered.
Biomedicines,
Год журнала:
2023,
Номер
11(2), С. 451 - 451
Опубликована: Фев. 3, 2023
The
SARS-CoV-2
(severe
acute
respiratory
syndrome
coronavirus
responsible
for
the
COVID-19
disease)
uses
Spike
proteins
of
its
envelope
infecting
target
cells
expressing
on
membrane
angiotensin
converting
enzyme
2
(ACE2)
that
acts
as
a
receptor.
To
control
pandemic,
genetically
engineered
vaccines
have
been
designed
inducing
neutralizing
antibodies
against
proteins.
These
do
not
act
like
traditional
protein-based
vaccines,
they
deliver
message
in
form
mRNA
or
DNA
to
host
then
produce
and
expose
protein
(from
which
it
can
be
shed
soluble
form)
alert
immune
system.
Mass
vaccination
has
brought
light
various
adverse
effects
associated
with
these
based
mainly
affecting
circulatory
cardiovascular
ACE2
is
present
membrane-bound
several
cell
types,
including
mucosa
upper
gastrointestinal
tracts,
endothelium,
platelets,
plasma.
converts
vasoconstrictor
II
into
peptides
vasodilator
properties.
Here
we
review
pathways
immunization
molecular
mechanisms
through
protein,
either
from
encoded
by
mRNA-based
interferes
Renin-Angiotensin-System
governed
ACE2,
thus
altering
homeostasis
circulation
Understanding
interactions
consequent
impact
system
will
direct
diagnosis
therapy
vaccine-related
provide
information
development
personalized
considers
pathophysiological
conditions
predisposing
such
events.
Seminars in Thrombosis and Hemostasis,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 27, 2025
Abstract
Travel-related
thrombosis
(TRT),
encompassing
deep
vein
(DVT)
and
pulmonary
embolism
(PE),
poses
a
significant
health
risk
associated
with
long-haul
travel.
Prolonged
immobility,
dehydration,
cabin
pressure
changes
during
flights
contribute
to
venous
stasis,
hypoxia,
hypercoagulability,
collectively
increasing
the
of
thromboembolism
(VTE).
While
absolute
TRT
is
relatively
low
in
population
overall,
it
rises
significantly
among
high-risk
groups,
including
individuals
history
VTE,
thrombophilia,
pregnancy,
or
recent
surgery.
This
review
explores
epidemiology,
pathophysiology,
clinical
presentation,
diagnostic
evaluation
while
highlighting
importance
early
recognition
prevention.
Risk
assessment
models
can
provide
guidance
for
identifying
at-risk
travelers.
Preventive
strategies
include
pharmacological
prophylaxis
low-molecular-weight
heparin
(LMWH)
nonpharmacological
measures
such
as
compression
stockings,
intermittent
pneumatic
compression,
mobility
exercises,
hydration.
Guidelines
from
international
societies
recommend
tailored
interventions
based
on
individual
profiles,
randomized
controlled
trials
are
scarce.
Given
that
travel
dramatically
expands,
this
critically
analyzes
available
management
various
settings,
aiming
increase
awareness
global
issue.
Biomedicines,
Год журнала:
2024,
Номер
12(4), С. 913 - 913
Опубликована: Апрель 20, 2024
Background:
Post-acute
sequelae
of
SARS-CoV-2
infection
(PASC)
is
a
complicated
disease
that
affects
millions
people
all
over
the
world.
Previous
studies
have
shown
PASC
impacts
10%
infected
patients
which
50–70%
are
hospitalised.
It
has
also
been
10–12%
those
vaccinated
against
COVID-19
were
affected
by
and
its
complications.
The
severity
later
development
symptoms
positively
associated
with
early
intensity
infection.
Results:
generated
health
complications
caused
involve
vast
variety
organ
systems.
Patients
diagnosed
neuropsychiatric
neurological
symptoms.
cardiovascular
system
involved
several
diseases
such
as
myocarditis,
pericarditis,
coronary
artery
reported.
Chronic
hematological
problems
thrombotic
endothelialitis
hypercoagulability
described
conditions
could
increase
risk
clotting
disorders
coagulopathy
in
patients.
Chest
pain,
breathlessness,
cough
respiratory
long-COVID
causing
distress
syndrome.
observed
immune
notable,
involving
diseases.
renal
was
impacted,
resulted
raising
issues,
fibrosis,
sepsis.
Endocrine
gland
malfunction
can
lead
to
diabetes,
thyroiditis,
male
infertility.
Symptoms
diarrhea,
nausea,
loss
appetite,
taste
among
reported
observations
due
gastrointestinal
disorders.
Skin
abnormalities
might
be
an
indication
long-term
implications
persistent
cutaneous
complaints
linked
PASC.
Conclusions:
Long-COVID
multidimensional
syndrome
considerable
public
implications,
affecting
physiological
systems
demanding
thorough
medical
therapy,
more
study
address
underlying
causes
effects
needed.
British Journal of Biomedical Science,
Год журнала:
2022,
Номер
79
Опубликована: Сен. 6, 2022
The
World
Health
Organisation
has
reported
that
the
viral
disease
known
as
COVID-19,
caused
by
SARS-CoV-2,
is
leading
cause
of
death
a
single
infectious
agent.
This
narrative
review
examines
certain
components
pandemic:
its
origins,
early
clinical
data,
global
and
UK-focussed
epidemiology,
vaccination,
variants,
long
COVID.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Сен. 28, 2023
Thrombocytopenia,
characterized
by
a
decrease
in
platelet
count,
is
commonly
observed
sepsis
and
COVID-19.
In
sepsis,
thrombocytopenia
can
result
from
various
mechanisms,
including
impaired
production
the
bone
marrow,
accelerated
destruction
due
to
increased
inflammation,
sequestration
of
platelets
spleen,
immune-mediated
destruction,
or
dysregulated
host
responses.
Similarly,
has
been
reported
COVID-19
patients,
but
immune-related
mechanisms
underlying
this
association
remain
unclear.
Notably,
interventions
targeting
have
shown
potential
for
improving
outcomes
both
patients.
Understanding
these
crucial
developing
effective
treatments.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(6), С. 5644 - 5644
Опубликована: Март 15, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
new
virus
discovered
in
December
2019
that
causes
disease
19
(COVID-19)
and
various
vaccinations
have
been
developed.
The
extent
to
which
COVID-19
infections
and/or
alter
antiphospholipid
antibodies
(aPL)
patients
with
thromboembolic
(APS)
remains
unclear.
Eighty-two
confirmed
APS
were
included
this
prospective
non-interventional
trial.
Blood
parameters
including
lupus
anticoagulants,
anticardiolipin
IgG-
IgM-antibodies,
anti-ß2-glycoprotein
I
IgM-antibodies
assessed
prior
after
vaccination
infection.
No
increases
aPL
the
total
study
population
detected.
In
fact,
low
but
significant
decreases
observed
for
anti-β2-glycoprotein
IgG-antibodies,
while
IgM-
anti-b2-glycoprotein
slightly
increased
only
infection
vaccination.
Although
investigated
patient
group
known
high
risk
of
recurrent
thrombosis,
one
arterial
thrombotic
event
was
diagnosed
(1.2%,
1/82).
This
recurrence
rate
probably
due
rates
effective
anticoagulation.
Our
data
show
do
not
deteriorate
clinical
course
anticoagulated
patients.
Military Medical Research,
Год журнала:
2024,
Номер
11(1)
Опубликована: Дек. 16, 2024
Abstract
Sepsis,
characterized
as
life-threatening
organ
dysfunction
resulting
from
dysregulated
host
responses
to
infection,
remains
a
significant
challenge
in
clinical
practice.
Despite
advancements
understanding
host-bacterial
interactions,
molecular
responses,
and
therapeutic
approaches,
the
mortality
rate
associated
with
sepsis
has
consistently
ranged
between
10
16%.
This
elevated
highlights
critical
gaps
our
comprehension
of
etiology.
Traditionally
linked
bacterial
fungal
pathogens,
recent
outbreaks
acute
viral
infections,
including
Middle
East
respiratory
syndrome
coronavirus
(MERS-CoV),
influenza
virus,
severe
2
(SARS-CoV-2),
among
other
regional
epidemics,
have
underscored
role
pathogenesis
sepsis,
particularly
when
critically
ill
patients
exhibit
classic
symptoms
indicative
sepsis.
However,
many
cases
viral-induced
are
frequently
underdiagnosed
because
standard
evaluations
typically
exclude
panels.
Moreover,
these
viruses
not
only
activate
conventional
pattern
recognition
receptors
(PRRs)
retinoic
acid-inducible
gene-I
(RIG-I)-like
(RLRs)
but
also
initiate
primary
antiviral
pathways
such
cyclic
guanosine
monophosphate
adenosine
(GMP-AMP)
synthase
(cGAS)-stimulator
interferon
genes
(STING)
signaling
response
mechanisms.
Such
activations
lead
cellular
stress,
metabolic
disturbances,
extensive
cell
damage
that
exacerbate
tissue
injury
while
leading
spectrum
manifestations.
complexity
poses
substantial
challenges
for
management
affected
cases.
In
this
review,
we
elucidate
definition
diagnosis
criteria
synthesizing
current
knowledge
regarding
its
etiology,
epidemiology,
pathophysiology,
mechanisms
involved
therein
well
their
impact
on
immune-mediated
damage.
Additionally,
discuss
considerations
related
both
existing
therapies
advanced
treatment
interventions,
aiming
enhance
comprehensive
surrounding